BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6417840)

  • 1. [Plasmafibronectin in case of tumors of the female genital system].
    Tatra G; Nasr F
    Strahlentherapie; 1983 Oct; 159(10):606-9. PubMed ID: 6417840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin plasma levels in gynecological cancers.
    Grammatikakis IE; Botsis DC; Grigoriou OV; Dalamanga AN; Creatsas GC
    J BUON; 2010; 15(1):122-6. PubMed ID: 20414938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
    Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prealbumin, transferrin and alpha-1-acid glycoprotein in patients with gynecological carcinomas.
    Tosner J; Krejsek J; Louda B
    Neoplasma; 1988; 35(4):403-11. PubMed ID: 3141823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of serum immunosuppresive acidic protein levels in gynecological tumor].
    Zhang W; Wang P; Zhao Y
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):194-6. PubMed ID: 11601039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of the serum concentration of pregnancy associated alpha 2 glycoprotein (alpha 2-PAG) in gynecologic carcinomas (author's transl)].
    Tatra G
    Strahlentherapie; 1981 Jul; 157(7):464-7. PubMed ID: 7268817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum levels of a immunosuppressive acidic protein in patients with gynecological cancer (author's transl)].
    Suzuki H; Miyoshi T; Sasaki H; Yoshida T
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):513-8. PubMed ID: 6785990
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasma fibrinogen in female patients with genital cancer and its early stage].
    Lober R; Krantz S; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):71-81. PubMed ID: 2581873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transient form of serum albumin in gynecologic cancer].
    Rybalka AN; Bagdasar'ian SN; Garina TN; Karpilenko TM; Kasymova GA
    Biull Eksp Biol Med; 1984 Jan; 97(1):76-9. PubMed ID: 6692030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of serum ferritin in female genital neoplasms].
    Dong MY
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The serum copper/serum iron ratio in malignant tumors of the female genitalia].
    Maas DH; Hinckers HJ
    Geburtshilfe Frauenheilkd; 1975 Aug; 35(8):619-26. PubMed ID: 1175904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrinogen degradation products in gynecologic neoplasms].
    Tatra G; Breitenecker G; Karsai I
    Fortschr Med; 1976 May; 94(13):752-4. PubMed ID: 955534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
    von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
    Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of circulating tumor necrosis factor-alpha in patients with gynecological malignancies.
    De Jaco P; Asselain B; Orlandi C; Fridman WH; Teillaud JL
    Int J Cancer; 1991 May; 48(3):375-8. PubMed ID: 2040531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive acidic protein in patients with gynecologic cancer].
    Sawada M; Matsui Y; Okudaira Y; Shimizu Y; Takayama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):605-11. PubMed ID: 6408203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression.
    Fenoglio CM; Crum CP; Pascal RR; Richart RM
    Diagn Gynecol Obstet; 1981; 3(4):291-9. PubMed ID: 7338157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
    Riisbro R; Stephens RW; BrĂ¼nner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
    Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Haptoglobins in gynecologic tumors (author's transl)].
    Tatra G; Moser C
    Strahlentherapie; 1978 May; 154(5):323-7. PubMed ID: 418536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum ferritin and trophoblastic globulin in genital tumors in women].
    Griaznova IM; Borisenko SA; Markarov OV; Fomina MB; Prokopenko PG; Tatarinov IuS
    Vopr Onkol; 1990; 36(2):181-7. PubMed ID: 2180208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.